✦ LIBER ✦

Cost Utility of Sirolimus versus Tacrolimus for the Primary Prevention of Graft Rejection in Renal Transplant Recipients in Mexico

✍ Scribed by Rely, Kely; Galindo-Suárez, Rosa María; Alexandre, Pierre K.; García-García, Erika Gabriela; Muciño-Ortega, Emilio; Salinas-Escudero, Guillermo; Martínez-Valverde, Silvia

Book ID: 122848784
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 490 KB
Volume: 1
Category: Article
ISSN: 2212-1099
DOI: 10.1016/j.vhri.2012.09.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PUK20 Cost-Utility Assessment of Sirolim

PUK20 Cost-Utility Assessment of Sirolimus Versus Tacrolimus for Primary Prevention of Graft Rejection in Renal Transplant Recipients in Mexico

✍ K. Rely; P.K. Alexandre; E.G. García-García; E. Muciño-Ortega; G. Salinas-escude 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PUK9 EVALUATION OF THE COST UTILITY OF S

PUK9 EVALUATION OF THE COST UTILITY OF SIROLIMUS VERSUS TACROLIMUS FOR IMMUNOSUPPRESSION FOR RENAL TRANSPLANTATION IN THE UNITED KINGDOM

✍ CJ Currie; S Dixon; P Conway; P McEwan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Sirolimus is effective for prevention of

Sirolimus is effective for prevention of acute rejection in primary mismatched renal allograft recipients

✍ C Ponticelli 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 65 KB

A retrospective analysis of a sirolimus/

A retrospective analysis of a sirolimus/prograf regimen for the prevention of acute rejection in recipients of primary mismatched renal allografts

✍ N Youseff; S Small 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 90 KB

A prospective randomized trial comparing

A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants

✍ Vandad Raofi; Dawn M Holman; Noreen Coady; Eva Vazquez; Ty B Dunn; Amelia M Bart 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Sirolimus in Combination with Cyclospori

Sirolimus in Combination with Cyclosporine or Tacrolimus Plus Methotrexate for Prevention of Graft-versus-Host Disease following Hematopoietic Cell Transplantation from Unrelated Donors

✍ Terry Furlong; Hans-Peter Kiem; Frederick R. Appelbaum; Paul A. Carpenter; H. Jo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 150 KB